Investors should focus on the adjusted net income of $17.5 million as a better indicator of ongoing profitability. The one-time tax benefit is not repeatable, so future quarters will likely show lower net income unless operational performance improves. Monitor future guidance for any changes in revenue or expense outlook.
Price Chart
Executive Summary
TransMedics provided additional details on its Q4 2025 financial results, clarifying that the previously reported $105.4 million net income included a one-time $83.8 million tax benefit from releasing a $103.3 million U.S. valuation allowance. Adjusted net income for the quarter was $17.5 million. The company reaffirmed its expectation of future tax provisions aligning with statutory rates.
Key Financial Metrics
Key Facts
- TransMedics released a $103.3 million U.S. tax valuation allowance in Q4 2025, resulting in an $83.8 million net income tax benefit.
- Reported Q4 2025 net income was $105.4 million; adjusted net income, excluding the tax benefit, was $17.5 million.
- The annual effective tax rate for 2025 was (77.0)%, but would have been 19.1% without the valuation allowance release.
- The company expects future quarterly tax provisions to be in line with U.S. statutory corporate income tax rates.
Financial Impact
The one-time tax benefit of $83.8 million inflated Q4 net income by $87.9 million compared to adjusted figures. The core business generated $17.5 million in net income.
Risk Factors
- The significant one-time tax benefit may lead to unrealistic expectations for future profitability.
- The company has a material weakness in internal control over financial reporting, which could affect future financial statements.
- Future financial performance is subject to risks including market acceptance of the OCS, regulatory developments, and ability to sustain profitability.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-079392 |
| Document: d80286dex991.htm | 0001193125-26-079392 |
| Document: 0001193125-26-079392-index-headers.html | 0001193125-26-079392 |
| Document: 0001193125-26-079392-index.html | 0001193125-26-079392 |
| Document: 0001193125-26-079392.txt | 0001193125-26-079392 |
| CONTEXT: Previous Earnings (2026-02-24) | 0001193125-26-066953 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 12, 2026 16w ago | Institutional Cluster | $72.91 $88.27 | ▲ +21.07% | ▲ +17.80% | $78.63 (+7.85%) |
Jun 11, 2026 16w ago | Institutional Cluster | $73.59 $89.98 | ▲ +22.27% | ▲ +17.88% | $78.63 (+6.85%) |
Apr 10, 2026 25w ago | DEFA14A | $114.00 $71.12 | ▼ −37.62% | ▼ −47.95% | $78.63 (−31.03%) |
Mar 2, 2026 30w ago | Insider Cluster | $147.00 $70.46 | ▼ −52.07% | ▼ −61.39% | $78.63 (−46.51%) |
Feb 27, 2026 31w ago | 8-K | $145.26 $70.46 | ▼ −51.49% | ▼ −60.88% | $78.63 (−45.87%) |
Feb 24, 2026 31w ago | 8-K | $131.85 $68.00 | ▼ −48.43% | ▼ −55.38% | $78.63 (−40.36%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access